Eli Lilly & Co. (LLY)
1157.35
+14.23
(+1.24%)
USD |
NYSE |
Oct 06, 16:00
1158.88
+1.53
(+0.13%)
After-Hours: 20:00
Eli Lilly Market Cap : 1.090T for Oct. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 05, 2026 | 1.076T |
| October 02, 2026 | 1.076T |
| October 01, 2026 | 1.083T |
| September 30, 2026 | 1.089T |
| September 29, 2026 | 1.115T |
| September 28, 2026 | 1.115T |
| September 25, 2026 | 1.114T |
| September 24, 2026 | 1.113T |
| September 23, 2026 | 1.084T |
| September 22, 2026 | 1.102T |
| September 21, 2026 | 1.097T |
| September 18, 2026 | 1.085T |
| September 17, 2026 | 1.085T |
| September 16, 2026 | 1.071T |
| September 15, 2026 | 1.070T |
| September 14, 2026 | 1.072T |
| September 11, 2026 | 1.050T |
| September 10, 2026 | 1.057T |
| September 09, 2026 | 1.058T |
| September 08, 2026 | 1.058T |
| September 04, 2026 | 1.082T |
| September 03, 2026 | 1.092T |
| September 02, 2026 | 1.092T |
| September 01, 2026 | 1.092T |
| August 31, 2026 | 1.089T |
| Date | Value |
|---|---|
| August 28, 2026 | 1.106T |
| August 27, 2026 | 1.107T |
| August 26, 2026 | 1.120T |
| August 25, 2026 | 1.161T |
| August 24, 2026 | 1.174T |
| August 21, 2026 | 1.182T |
| August 20, 2026 | 1.172T |
| August 19, 2026 | 1.205T |
| August 18, 2026 | 1.154T |
| August 17, 2026 | 1.114T |
| August 14, 2026 | 1.111T |
| August 13, 2026 | 1.138T |
| August 12, 2026 | 1.149T |
| August 11, 2026 | 1.144T |
| August 10, 2026 | 1.160T |
| August 07, 2026 | 1.116T |
| August 06, 2026 | 1.122T |
| August 05, 2026 | 1.101T |
| August 04, 2026 | 1.050T |
| August 03, 2026 | 1.056T |
| July 31, 2026 | 1.082T |
| July 30, 2026 | 1.087T |
| July 29, 2026 | 1.139T |
| July 28, 2026 | 1.149T |
| July 27, 2026 | 1.127T |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 613.57B |
| Merck & Co., Inc. | 350.37B |
| Pfizer Inc. | 156.58B |
| Bristol Myers Squibb Co. | 121.72B |
| Structure Therapeutics, Inc. | 1.959B |
Market Cap Related Metrics
| PE Ratio | 39.33 |
| PS Ratio | 13.20 |
| PEG Ratio | 0.4134 |
| Price to Book Value | 32.16 |
| Price to Free Cash Flow | 77.52 |
| Price | 1157.35 |
| Earnings Yield | 2.54% |
| PEGY Ratio | 0.4109 |
| Operating PE Ratio | 26.54 |
| Normalized PE Ratio | 33.93 |